Attovia Therapeutics Insider Trades

Over the last 12 months, Attovia Therapeutics insiders reported 56 transactions on SEC Form 4: 5 open-market purchases and 46 sales. Insiders bought $25.7 million and sold $4.5 million worth of stock, for net insider buying of $21.2 million. The largest seller was GOLDMAN SACHS GROUP INC & GOLDMAN SACHS & CO. LLC & GOLDMAN SACHS ASSET MANAGEMENT, L.P. & Broad Street Principal Investments, L.L.C. & WSLS OFFSHORE INVESTMENTS, SLP & West Street Life Sciences I, L.P. & WSLS EMP OFFSHORE INVESTMENTS, L.P. & WSLS EMP ONSHORE INVESTMENTS, L.P., with $4.5 million in reported sales.

The most recent filing shows GOLDMAN SACHS GROUP INC & GOLDMAN SACHS & CO. LLC & GOLDMAN SACHS ASSET MANAGEMENT, L.P. & Broad Street Principal Investments, L.L.C. & WSLS OFFSHORE INVESTMENTS, SLP & West Street Life Sciences I, L.P. & WSLS EMP OFFSHORE INVESTMENTS, L.P. & WSLS EMP ONSHORE INVESTMENTS, L.P. (Former 10% Owner) reporting a transaction in 1,957,134 shares on Aug 6, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ATTO's ownership changes in context.